Properties of calcium binding by Myxicola axoplasmic protein.
The 45Ca2+ binding properties of axoplasmic protein from the Myxicola giant axon have been investigated using a centrifugal/concentration-dialysis technique. Scatchard plot analysis of these binding data suggest that Ca2+ is attached to a site with an equilibrium dissociation constant of 7.7 +/- 0.5 microM and a capacity of 4.4 +/- 0.2 mumol/g axoplasmic protein (n = 11). Addition of other cations--Cd2+, Mn2+, Al3+, Cu2+, Ba2+, and Zn2(+)--at concentrations up to 10 microM did not displace 0.2 microM 45Ca2+ from its binding site, probably because of buffering of these cations by amino acid residues within the protein solutions. The protein could be stored at 4 degrees C for up to 16 days with no appreciable change in the number of calcium sites. Ca2+ binding equilibrium took place in less than 30 min of incubation. Increasing the incubation temperature from 4 degrees C to 37 degree C reduced the number of Ca2+ sites. The binding capacity was reduced by one-half when the protein was dialyzed with 4 M urea or high ionic strength KCl (2 M). Calcium binding was examined as a function of pH. When the protein was dialyzed overnight at different pH values and all the binding was done at pH 7.0, the apparent number of Ca2+ sites decreased as the pH of the dialysis medium was increased. When the protein was dialyzed overnight at pH 7.0 and the binding was done at different pH values, the apparent binding capacity increased as pH increased.(ABSTRACT TRUNCATED AT 250 WORDS)
al-Baldawi
N F
NF
Department of Physiology, Emory University School of Medicine, Atlanta, Georgia.
Abercrombie
R F
RF
D000535:Aluminum / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001369:Axons / Q000737:chemistry / Q000378:metabolism; D001464:Barium / Q000378:metabolism; D001667:Binding, Competitive; D002104:Cadmium / Q000378:metabolism; D002118:Calcium / Q000032:analysis / Q000378:metabolism*; D002147:Calmodulin / Q000037:antagonists & inhibitors; D002457:Cell Extracts; D003300:Copper / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D006902:Hydroxymercuribenzoates / Q000494:pharmacology; D008274:Magnesium / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000378:metabolism*; D009994:Osmolar Concentration; D011077:Polychaeta / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology; D013696:Temperature; D015032:Zinc / Q000378:metabolism
D000596:Amino Acids; D002147:Calmodulin; D002457:Cell Extracts; D006902:Hydroxymercuribenzoates; D009419:Nerve Tissue Proteins; D013449:Sulfonamides; D002104:Cadmium; C030601:4-hydroxymercuribenzoate; D001464:Barium; C017967:W 7; D003300:Copper; C034700:N-(6-aminohexyl)-1-naphthalenesulfonamide; D000535:Aluminum; D008274:Magnesium; D015032:Zinc; D002118:Calcium